PSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Third Consecutive Month – NBCNEWS

  • Whatsapp

LAS VEGAS, NV, Aug. 3, 2022 (GLOBE NEWSWIRE) — PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”), a media leader focused on the emerging psychedelic sector, announced that its flagship platform, Psychedelic, surpassed Spotlight one million page views in July and set new monthly records for the following KPIs: page views, impressions, organic visits, and click-through rate (CTR).

Read More

The achievement comes after Psychedelic Spotlight first surpassed a million page views in the months from May and June. This is the company’s first time reaching this milestone, and the development, combined with its continued top position on Google in the “psychedelic news” search category, confirms management’s claim that Psychedelic Spotlight is the most recognized and respected leader for psychedelic news. , information and unique perspectives within the sector.

According to the company, the operational highlights of Psychedelic Spotlight in July 2022 are as follows:

  • Pageviews: 1.2 million
  • Impressions: 1.58M
  • CTR: 6.6%
  • Organic visits: 117.5K
  • July 2022 about July 2021 Growth: Pageviews 639% | Impressions 298% | CTR 119%

“Psychedelic Spotlight was just two years ago an obscure website with maybe 10-15 articles and feature articles, with no established brand identity or audience. We are incredibly proud of our team for growing it into the juggernaut it is today,” said PSYC CEO David Flores.

“The evolution of Psychedelic Spotlight into a formidable multimedia leader in the medicinal psychedelics industry, in my view, offers PSYC a tangible asset that not only lays the foundation for our longer-term growth initiatives, but also plays an active role in attracting and taking advantage of new opportunities that could have a direct impact on some of our short-term initiatives. While nothing is final at this point, I am absolutely encouraged by the opportunities actively explored by PSYC thus far in Q3. Each of them, from my perspective, came to us as a direct result of the identity, audience and value we’ve created through Psychedelic Spotlight, so I remain cautiously optimistic about the future of PSYC.”

Psychedelic Spotlight Marketing Director Maria Holyanova praised the platform’s monthly performance. “Psychedelic Spotlight’s organic growth proves that we are capable of executing our strategies even in difficult times. Over the past month, our team has updated its game plan, ultimately leading to a higher ranking for Psychedelic Spotlight on Google Search and Google News. This points not only to adaptable real-time work strategies, but also to a growing interest in the potential benefits of psychedelics. As the audience for the psychedelic space continues to grow, Psychedelic Spotlight strives not only to deliver information in an unbiased and informative way, but also to contribute to harm reduction and a healthier, happier society.”

Psychedelic Spotlight Executive Director Swati Sharma elaborated on the growing influence of Psychedelic Spotlight on conversations within the psychedelic space. “Our ability to reach over 1 million pageviews for the platform and sustain it for several months continues to prove that Psychedelic Spotlight is experiencing upward growth for the foreseeable future. Not only have we built this number of followers, but we are consistently at the top of Google thanks to our organic growth, continuing to deliver value to our own reach, trusted partners and media partners. We are so excited about the impact we have had within the psychedelic industry, and we expect our influence to continue to grow as we incorporate more health and wellness topics into our ever-changing content and media strategies.

PSYC CFO Craig Schlesinger concluded: “The year-over-year growth trends of Psychedelic Spotlight are undeniable. Last month, the platform passed the 100,000 organic visits milestone for the first time, reaching a new record this month with over 117,000 organic visits. Our audience continues to grow as interest in psychedelics spreads and sheds old stigmas. In addition, investor demand for PSYC increased in July as the stock gained 20% over the month, coupled with increased trading volume. Investors are certainly taking note of Psychedelic Spotlight’s dynamic growth. Immediately recent research with an estimate of the future value of the medicinal psychedelics industry at $7 billion+ by 2026, it is an exciting time for Team PSYC.”

The charts below are for informational purposes only. Data from Google Analytics.

About PSYC Corporation (OTCPink: PSYC)

At PSYC Corporation, we integrate media, creativity and technology to develop and implement thought-provoking ideas and solutions that advance and transform approaches to some of society’s most pressing issues.

PSYC has expressed its intention and commitment to position itself at the forefront of the psychedelic revolution and as an information center for discovering and understanding the latest research and business opportunities surrounding psychedelic-inspired medicines. Coupled with the FDA’s more open-minded approach to psychedelic drugs, and as several major U.S. cities continue to approve the decriminalization of psilocybin, we think investors are speculating that the psychedelic boom could outpace that of cannabis. PSYC is your source for current investment-related news specific to psychedelic drugs and cutting-edge research to improve overall health, bringing this industry mainstream.

We are committed to a forward-thinking approach that embraces breakthrough new technology and innovations and through the vision of business development, we intend to continue evolving into these unknown areas as the industry leaders of the future.

Forward-Looking Statements Disclaimer:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “maybe”, “ongoing”. ”, “plan”, “potential”, “forecast”, “project”, “would”, “will”, “would”, or the negative of these terms or other similar terminology, although not all forward-looking statements contain them. words. Forward-looking statements are not guarantees of future performance or results and are not necessarily accurate indications of the times when or by which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors, including the effect of COVID-19 and the success of current vaccine distribution, the adverse effect of the Omicron variant, which could cause our results, activity levels, performance or performance to differ materially from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all of the Company’s filings disclosed on the OTC Markets.com website and is not incorporated by reference into any such reports.

Disclaimer: PSYC Corporation does not in any way encourage or endorse the use, purchase, sale, or transfer of illegal substances, nor do we encourage or endorse participation in any illegal activity. We support a harm reduction approach to educate and promote individual and public safety. If you choose to use psychedelics, do so responsibly.

Business contact:
PSYC Corporation (PSYC)
www.psyccorporation.com
(702) 330-0363
[email protected]
OTC PINK: PSYC

The content is from GlobeNewswire. DKODING Media is not responsible for the content offered or any links related to this content. DKODING Media is not responsible for the accuracy, timeliness or quality of the content.

Related posts

Leave a Reply